Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Laurus Labs receives EIR from USFDA for API facilities
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Subscribe To Our Newsletter & Stay Updated